Clinical Trial

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

Name: Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies — clinical trial record (NCT06508775)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LONGSAFE

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2024-07-16; most recent amendment 2025-11-20.

Trial Details

NCT Number	NCT06508775
Lead Sponsor	Miltenyi Biomedicine GmbH
Conditions	Melanoma Stage III, B-cell Non Hodgkin Lymphoma, Pediatric ALL, Childhood Non-Hodgkin Lymphoma, Acute Lymphatic Leukemia, Chronic Lymphatic Leukemia, Melanoma Stage IV
Enrollment	40 participants
Start Date	2024-05-05
Primary Completion	2040-12-31 (estimated)
Study Completion	2040-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-11-26